Presbyterian Hospital of Dallas chose to install BrainSUITE because it is committed to offering innovative neurosurgical treatment options to its patients. BrainSUITE will augment Presbyterian Hospital of Dallas' brain tumour programme, which offers a variety of surgical and non-surgical treatment options, including intra-arterial chemotherapy for inoperable brain tumours and GliaSite irradiation therapy for recurrent tumours.
BrainSUITE is a turnkey solution for the treatment of complicated neurosurgical cases. The integrated Siemens ESPREE wide-bore 1.5 Tesla high-field (MR) scanner allows surgeons to verify the complete resection of a brain tumour before finalizing the operation. In addition, the diagnostic images needed for navigated neurosurgery can be updated during the procedure, making the surgery more precise and much safer for the patient. Due to better tumour resection control, BrainSUITE promises to lower re-operation and complication rates, and increase navigation accuracy, thus helping hospitals to contain treatment costs and providing patients with better care.
BrainSUITE has been designed and pre-tested to provide MR compatibility, MR safety and software integration. This new fully integrated neurosurgical suite brings patients and surgeons one of the most cutting-edge neurosurgical operating rooms available today. "Throughout its 40-year-history, Presbyterian Hospital of Dallas has demonstrated forward-thinking in its commitment to technologically advanced clinical care in neurosurgical services", stated Mark H. Merrill, hospital president. "BrainSUITE will allow us to continue our commitment to patients well into the future."
Established in May 1966, Presbyterian Hospital of Dallas celebrates its 40th Anniversary in 2006 as the flagship hospital of the non-profit, faith-based Presbyterian Healthcare System; a member of Texas Health Resources. Recognized for excellence in services for women and infants, cardiovascular, orthopaedic, neuroscience, digestive/surgery, oncology and outpatient care, Presbyterian Hospital of Dallas is a regional referral hospital for North Texas and beyond. The 866-bed facility has approximately 4000 employees and an active medical staff of more than 1000 physicians.
BrainLAB, a privately held company headquartered in Munich, Germany, was founded in 1989 and is specialized in the development, manufacture, and marketing of medical technology for radiosurgery and radiotherapy, orthopaedics, neurosurgery, and ENT. Among the products developed by BrainLAB are software and hardware components for image-guided surgery and radiotherapy as well as integrated systems for stereotactic radiosurgery. With around 2170 systems installed in over 65 countries, BrainLAB is among the market experts in image-guided medical technology. BrainLAB today employs 740 people worldwide and has 15 offices across Europe, Asia, North and South America and Australia. More company news is available in the VMW September 2005 article BrainLAB collaborates with Synthes and Biomet to advance trauma, spine, hips, knees, and maxillofacial surgery.